After completing his degree and PhD at Aston University, Andy spent his early career with ICI, working in the area of advanced polymer membranes and subsequently with Johnson & Johnson leading projects in absorbent technologies. Andy joined Biocompatibles UK in 1996 and is Director of R&D in Innovation (now part of BTG). He specialises in the development of advanced biomedical polymer systems, for instance, to enhance the biocompatibility of implants or to modulate delivery of active agents in the body. These technologies have been applied to novel drug-device combination products for use in interventional therapies in the treatment of cardiovascular disease and cancer.